Stock Exchange Releases – FIT Biotech

Reports and Releases

Stock exchange releases

2018/11/27

FIT Biotech Oy: EHVA starts recruiting participants to clinical trial testing FIT Biotech's vaccine

2018/11/22

FIT Biotech Oy: FIT Biotech expands R&D pipeline

2018/11/12

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2018/10/17

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/10/04

FIT Biotech Oy: FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus

2018/09/27

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2018/09/21

FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY SEPTEMBER 21, 2018

2018/09/19

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/09/13

FIT Biotech Oy: FIT Biotech withdraws a patent application

2018/09/06

FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2018

2018/08/31

FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY

2018/08/30

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/08/24

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/08/20

FIT Biotech Oy: Correction to company release dated August 16th, 2018: Chairman of the board on leave of absence

2018/08/16

FIT Biotech Oy: FIT Biotech concludes the exploration of secondary listing to First North Sweden -not relevant at the moment

FIT Biotech Oy: Chairman of the board on leave of absence

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2018/08/07

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/07/25

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/07/05

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/07/04

CORRECTION FIT Biotech Oy: FIT Biotech's company site has been launched in Inderes.fi

2018/07/02

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2018/06/26

FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK

2018/06/25

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/06/12

FIT Biotech Oy: First EHVA clinical trial authorization granted for testing FIT-06

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/05/25

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/05/23

FIT Biotech Oy: FIT Biotech files two international patent applications

2018/05/22

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - FIT Biotech's own equity positive with draw down of fourth Tranche

FIT Biotech Oy: Positive results from gene therapy collaboration with Avacta

2018/05/17

FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of April - FIT Biotech Ltds' equity will be positive with draw down of the fourth tranche

2018/05/11

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

2018/05/07

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/04/27

FIT Biotech Oy: APPOINTMENT OF TOMMI HOLOPAINEN AS CFO AND AS A MEMBER OF THE MANAGEMENT TEAM OF FIT BIOTECH

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/04/24

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/04/18

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/04/16

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

2018/04/12

FIT Biotech Oy: Resolutions of the Annual General Meeting and the Board of FIT Biotech Oy on April 12, 2018

2018/03/29

CORRECTION: FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2018/03/22

FIT Biotech Oy: Notice Convening the 2018 Annual General Meeting of FIT Biotech Oy

2018/03/21

FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018

2018/03/15

FIT Biotech Oy: FIT Biotech's Review of Operations and Financial Statement 2017 published

2018/03/14

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/03/09

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

2018/03/06

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/03/02

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/03/01

FIT Biotech Oy: FIT BIOTECH OY FINANCIAL STATEMENT BULLETIN JANUARY 1 - DECEMBER 31, 2017

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/02/26

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - last conversion of Bracknor financing programme

2018/02/22

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/02/21

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

2018/02/19

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/02/14

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing

2018/02/13

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/02/08

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/02/06

FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY FEBRUARY 6, 2018

2018/01/31

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

2018/01/29

Correction to company release dated January 26, 2018 - Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - number of shares

2018/01/26

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/01/18

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

FIT Biotech Oy: FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO

2018/01/16

FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY

2018/01/15

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2018/01/10

FIT Biotech Oy: FIT Biotech's EUR 10 million financing agreements' share loan and first part of commitment fee related shares have been handed over today to Alpha Blue Ocean

2018/01/05

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/12/29

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/12/28

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/12/27

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself without payment

2017/12/23

FIT Biotech Oy: FIT Biotech enters into EUR 10 million financing - FIT Biotech's equity back to positive after first tranche financing received

2017/12/01

FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

2017/11/13

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/11/06

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/30

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/25

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/18

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/16

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/09

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/06

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/10/05

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/09/26

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/09/19

FIT Biotech: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/09/15

FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017

2017/09/11

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/09/01

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2017/08/28

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/08/23

FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board

2017/08/22

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/08/08

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/07/31

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/07/25

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/07/18

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2017/07/12

FIT Biotech Oy: FIT Biotech Receives EUR 644,868 Payment from European HIV Vaccine Alliance (EHVA)

2017/06/13

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2017/06/12

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/05/30

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/05/10

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/05/02

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2017/04/27

FIT Biotech Oy: APPOINTMENTS IN FIT BIOTECH'S MANAGEMENT

2017/04/25

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/04/07

FIT Biotech Oy: Resolutions of the Annual General Meeting and the Board of FIT Biotech Oy on April 7, 2017

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/04/04

FIT Biotech Oy: FIT Biotech has demonstrated proof-of-concept of its gene delivery vector in cancer models

2017/03/31

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

2017/03/30

FIT Biotech Oy: Appointment to FIT Biotech's Management Team

2017/03/24

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into Shares

2017/03/17

FIT Biotech Oy: FIT Biotech's Annual Report 2016 published

FIT Biotech Oy: Notice Convening the 2017 Annual General Meeting of FIT Biotech Oy

FIT Biotech Oy: Notice Convening the 2017 Annual General Meeting of FIT Biotech Oy

2017/03/16

FIT Biotech Oy: Notice Convening the 2017 Annual General Meeting of FIT Biotech Oy

2017/03/10

FIT Biotech Oy: FIT BIOTECH OY'S ANNUAL FINANCIAL REPORT JANUARY 1- DECEMBER 31, 2016

FIT Biotech Oy: FIT Biotech Ltd's own equity negative, convertible note loans converted into capital loans

2017/03/06

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/02/28

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2017/02/27

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/02/22

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/02/21

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/02/17

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/02/08

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into share

2017/01/26

FIT Biotech Oy: FIT Biotech Oy's Extraordinary General Meeting held on January 26th 2017 appointed Eero Rautalahti to the Board of Directors.

2017/01/24

FIT Biotech Oy: Conversion of FIT Biotech Oy s Convertible Notes into shares

2017/01/23

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/01/16

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/01/11

FIT Biotech Oy: FIT Biotech Oy has extended the registration day for the extraordinary General Meeting on January 26, 2017

2017/01/05

FIT Biotech Oy: Notice to the extraordinary General Meting

2017/01/04

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2017/01/02

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2016/12/22

Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/12/19

FIT Biotech Oy: FIT BIOTECH'S FINANCIAL INFORMATION SCHEDULE AND AGM 2017

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/12/16

FIT Biotech Oy: FIT Biotech partners with InnaVirVax for HIV Immunotherapy Clinical Development and Commercialization

2016/12/15

FIT Biotech Oy: Directed share issue of FIT Biotech Oy

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/12/02

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/11/28

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/11/22

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/11/10

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/11/09

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/11/08

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

2016/11/07

FIT Biotech Oy: FIT Biotech to receive grant funding from Tekes

2016/11/03

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/10/27

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/10/24

FIT Biotech Oy: Tekes issues a decision on the company's rectification request related to Tekes's claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

2016/10/20

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/10/14

FIT Biotech Oy: Correction to company release: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

FIT Biotech Oy: Correction to English company release: Conversion of FIT Biotech Oy's Convertible Notes into shares

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/10/03

FIT Biotech Oy: Liquidity Providing agreement with S-Pankki to expire

2016/09/30

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

2016/09/26

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the implementation of financing transactions between the Company and Bracknor Investment and between the Company and Sitra

2016/09/23

FIT Biotech Oy: Tekes issues a partial decision on the company's rectification request related to Tekes's claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

2016/09/15

FIT Biotech Oy: Resolutions of FIT Biotech Oy's Extraordinary General Meeting on September 15, 2016

2016/09/14

FIT Biotech Oy: FIT BIOTECH OY'S HALF-YEAR FINANCIAL REPORT JANUARY 1-JUNE 30, 2016

2016/09/09

FIT Biotech Oy: FIT Biotech's Certified Adviser to change

2016/09/05

FIT Biotech Oy: FIT Biotech to repeat it's proof-of-concept gene-based treatment study

FIT Biotech Oy: FIT Biotech will publish half-year financial report on September 14, 2016

2016/08/25

FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY

FIT Biotech Oy: FIT Biotech has agreed on a EUR 12,480,000 financing transaction with Bracknor Investment and intends to agree on a EUR 500,000 financing transaction with Sitra

FIT Biotech Oy: FIT Biotech's GMP facility audited and approved - the company resumes manufacturing of drug candidates

2016/07/04

FIT Biotech Oy: FIT BIOTECH PROMOTES LIISA LAITINEN TO SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

2016/06/22

FIT Biotech Oy: Tekes issues a claim to partly reclaim a capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

2016/06/16

FIT Biotech Oy: FIT Biotech expands collaboration with Icosagen in the development of gene-based treatments

2016/06/13

FIT Biotech Oy: FINANCIAL SUPERVISORY AUTHORITY HAS ISSUED A PUBLIC WARNING TO FIT BIOTECH OY

2016/06/10

FIT Biotech Oy: Research grant application related to Innovative Medicines Initiative 2 (IMI2) did not result in a positive decision

2016/06/09

FIT Biotech Oy: FIT Biotech's HIV vaccine demonstrated to be safe and well tolerated in two clinical studies

2016/05/20

FIT Biotech gives an update on its operational directions under new management

2016/04/19

FIT Biotech Oy: FIT Biotech appoints James Kuo, MD, MBA as new CEO

2016/04/08

FIT Biotech Oy: Resolutions of the Annual General Meeting and the Board of FIT Biotech Oy on April 8, 2016

2016/04/05

FIT Biotech Oy: Finnish FIT Biotech and US Ichor to collaborate on new cost effective infectious disease treatment

2016/03/22

FIT Biotech Oy: FIT Biotech Oy's Annual Report 2015 published in English

2016/03/18

FIT Biotech Oy: Notice Convening the 2016 Annual General Meeting of FIT Biotech Oy

FIT Biotech Oy : FIT Biotech Oy's Annual Report 2015 published

2016/03/11

Fit Biotech Oy: Financial Statements Bulletin of FIT Biotech Oy Jan 1-Dec 31, 2015

2016/03/07

FIT Biotech Oy lowers its profit forecast for the 2016 financial period and has started raising additional finance to ensure the implementation of its business plan and continuity of its business

2016/03/01

FIT Biotech Oy: Liquidity providing agreement between FIT Biotech Oy and FIM Sijoituspalvelut transferred to S-Pankki

2016/02/16

FIT Biotech Oy : Significant preclinical results for FIT Biotech in applying GTU® technology to gene therapy

2016/01/28

FIT Biotech Oy: FIT Biotech joins major European HIV-research collaboration

2016/01/21

FIT Biotech Oy: Changes in FIT Biotech's Management team and Board of Directors

2016/01/07

FIT Biotech Oy: FIT Biotech focusing on gene therapy

2016/01/04

FIT Biotech Oy: Changes in FIT Biotech's Board of Directors

2015/12/31

FIT Biotech Oy: FIT Biotech's long time CEO retires

2015/12/17

FIT Biotech Oy: FINANCIAL INFORMATION SCHEDULE AND AGM 2016

2015/10/22

Resolutions by FIT Biotech Oy's extraordinary general meeting on 22 October 2015 relating to the composition of the board of directors

2015/10/01

Notice convening an extraordinary general meeting of FIT Biotech Oy

2015/09/30

Converted K shares of FIT Biotech have been entered into the Trade Register

2015/09/29

FIT Biotech to study further the feasibility of its GTU®-technology in gene therapy

2015/09/14

Change in FIT Biotech's Management Team

2015/09/08

The Board of Directors of FIT Biotech Decides on Conversion of Shares

2015/08/31

HALF-YEAR INTERIM REPORT OF FIT BIOTECH OY JANUARY 1-JUNE 30, 2015

2015/08/14

FIT Biotech to publish H1/2015 Interim Report on August 31st, 2015 at 9.00 EET

2015/08/12

FIT Biotech reports change in the composition of the Board of Directors

2015/07/27

FIT Biotech appoints Dr. Milla Koistinaho as Chief Operating Officer

2015/07/16

The Board of Directors of FIT Biotech Decides on Conversion of Shares

2015/07/06

FIT Biotech in Consortium Selected For Final Negotiations with EC

2015/06/26

FIT Biotech's Initial Public Offering Completed Successfully

2015/06/16

FIT Biotech Oy Extending Subscription Period of its Offering

2015/06/01

FIT Biotech Ltd's listing prospectus has been published

2015/05/29

FIT Biotech Ltd's Board of Directors has decided on a share offering and on an application for the admission of the Company's series K shares to trading on the First North Finland market